Indications and uses
for the treatment and management of acne
for the treatment and management of acne
cleanse the skin thoroughly before applying apply over the entire affected area 1-3 times daily if bothersome dryness occurs, reduce application to once a day or every other day
DRUG FACTS
Colloidal Sulfur 3.25%
Acne Treatment
For external uses only
If swallowed, get medical help or contact a Poison Control Center right away.
1,2-Hexanediol, Bentonite, Bisabolol, Butylene Glycol, Camellia Sinensis Leaf Extract, Caprylic/Capric Triglyceride, Caprylyl Glycol, Cetearyl Alcohol, Disodium EDTA, Epilobium Angustifolium Flower/Leaf/Stem Extract, Farnesol, Glycerin, Glyceryl Oleate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Iron Oxides (CI 77491, CI 77492, CI 77499), Kaolin, Magnesium Aluminum Silicate, Menthol, Pentylene Glycol, Phytic Acid, Polysorbate 60, Potassium Sorbate, Propylene Glycol, Pueraria Lobata Root Extract, Quercetin Caprylate, Silica Dimethyl Silylate, Sodium Benzoate, Sodium Gluconate, Squalane, Stearyl Alcohol, Titanium Dioxide (CI 77891), Tropolone, Water (Aqua), Xanthan Gum
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 58633-223-10 | 2024-12-28 | C162847 | 48780-1 | 9d75b9d0-8461-f424-e053-dadaa90a57ce | Correct & Perfect Spot Treatment |
| 58633-223-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8461-f424-e053-dadaa90a57ce | Correct & Perfect Spot Treatment |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 58633-223 | 58633-223-10 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 24e669d3-fb46-4239-8bf6-650e3141ebf4 | 2e7cb53b-a85d-4648-af8c-28e36e577245 | 2024-12-29 | Warnings | 2e7cb53b-a85d-4648-af8c-28e36e577245 |
Adverse event summaries are temporarily unavailable. Other product information remains available.